Skip Links

  • Go to homepage [Accesskey '0']
  • Go to content [Accesskey '1']
  • Go to navigation [Accesskey '2']
  • Search site [Accesskey '3']
  • Go to footer links [Accesskey '4']
  • Go to accessibility page [Accesskey '5']
  • About us
  • Patients & carers
  • Health professionals
  • Investors
  • Media Center
  • Contact us
  • Home
  • >
  • Investors
  • >
  • Shareholder FAQs
Neuropharm

Investors

  • Share price
  • Financial summary
  • Annual & Interim reports
  • Financial calendar
  • Significant shareholders
  • Shareholder FAQs
  • Advisors
  • IR contacts
  • Compliance information - AIM Rule 26
  • Research notes

Shareholder FAQs

FAQs

  • Q1 What exchange is Neuropharm Group plc listed on?
  • Q2 What is the stock symbol for Neuropharm Group plc?
  • Q3 On what date did Neuropharm Group plc list?
  • Q4 What is Neuropharm Group plc’s current issued share capital?
  • Q5 Who is Neuropharm Group plc’s registrar?
  • Q6 How do I get hold of a copy of the latest Annual Report and Interim Report?
  • Q7 What do I do if I want to be notified of announcements by Neuropharm Group plc?

Q1 What exchange is Neuropharm Group plc listed on?

Neuropharm Group plc is listed on the Alternative Investment Market (”AIM”) of the London Stock Exchange.

Back to top

Related links

  • Share price Monitor our share price activity
  • RNS Read our RNS announcements

Contact us

  • UK office

Neuropharm Group plc
Fetcham Park House
Lower Road
Leatherhead
Surrey KT22 9HD
United Kingdom

T: +44 (0)1372 371 171

Email: UK office

  • US office

Neuropharm Inc.
Radnor Financial Center
150 N. Radnor Chester Rd
Suite F-200
Radnor, PA 19087
United States

T: +1 (610) 977 2420

Email: US office

Site by Radley Yeldar

© Neuropharm Group plc 2009

  • Sitemap
  • Privacy policy
  • Accessibility
  • Useful links
  • Glossary
  • Careers